BARCELOS
COMMUNICATION

The most effective marketing and public relations campaigns are not driven by creativity alone. They are shaped by emotional intelligence. Research in psychology and behavioral science consistently shows that emotion is the primary driver of human decision-making. Studies from Harvard Business School indicate that up to 95 percent of purchasing decisions are made subconsciously, guided largely by emotional response rather than rational analysis. Logic tends to follow emotion,

Clinical trials are meticulously designed to gather clinically relevant data while allowing participants to live their daily lives as normally as possible. However, these trials are inherently artificial environments where participants are closely monitored to ensure their safety and assess the efficacy of a developing drug. Participants are expected to remain engaged throughout the trial, providing the data needed by sponsors and the FDA to make informed decisions about drug

Machine learning (ML) innovation in clinical research holds significant promise for enhancing drug development and patient care. However, as with any emerging technology, its growing prevalence often brings increasing skepticism. Pharmaceutical sponsors and clinicians, accustomed to a highly regulated environment that demands rigorous documentation of a drug's development and efficacy, naturally approach ML-powered tools with caution. The concern is valid: these tools often p

Mental health is the silent crisis of our time, claiming millions of lives and affecting billions more, yet it remains shrouded in stigma and neglect.   The term "crisis" typically refers to a period of extreme difficulty or danger, often demanding urgent attention. We’ve seen this with the HIV/AIDS epidemic, SARS, and more recently, COVID-19—all crises that mobilized global responses. Yet, every year, mental health quietly takes a devastating toll, with 20% of U.S. adults ex